| Key Financial Ratios of Mankind Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
48.16 |
45.52 |
31.16 |
33.33 |
27.07 |
|
| Diluted EPS (Rs.) |
48.07 |
45.45 |
31.16 |
33.33 |
27.07 |
|
| Cash EPS (Rs.) |
56.31 |
53.45 |
37.89 |
36.35 |
29.02 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
354.83 |
240.24 |
194.31 |
151.50 |
118.18 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
354.83 |
240.24 |
194.31 |
151.50 |
118.18 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
230.19 |
231.28 |
202.88 |
181.16 |
138.04 |
|
| PBDIT/Share (Rs.) |
74.06 |
64.70 |
46.44 |
48.99 |
38.10 |
|
| PBIT/Share (Rs.) |
64.90 |
56.77 |
39.71 |
45.97 |
36.15 |
|
| PBT/Share (Rs.) |
55.89 |
56.41 |
39.01 |
44.87 |
35.95 |
|
| Net Profit/Share (Rs.) |
47.15 |
45.52 |
31.16 |
33.33 |
27.07 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
32.17 |
27.97 |
22.88 |
27.04 |
27.60 |
|
| PBIT Margin (%) |
28.19 |
24.54 |
19.57 |
25.37 |
26.18 |
|
| PBT Margin (%) |
24.27 |
24.38 |
19.22 |
24.76 |
26.04 |
|
| Net Profit Margin (%) |
20.48 |
19.68 |
15.35 |
18.39 |
19.61 |
|
| Return on Networth / Equity (%) |
13.28 |
18.94 |
16.03 |
22.00 |
22.90 |
|
| Return on Capital Employed (%) |
13.56 |
23.14 |
20.00 |
29.77 |
30.16 |
|
| Return on Assets (%) |
8.16 |
15.97 |
13.32 |
15.87 |
18.44 |
|
| Total Debt/Equity (X) |
0.50 |
0.00 |
0.00 |
0.11 |
0.02 |
|
| Asset Turnover Ratio (%) |
0.54 |
0.89 |
0.91 |
1.02 |
1.06 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.15 |
3.45 |
2.48 |
1.46 |
2.86 |
|
| Quick Ratio (X) |
0.88 |
2.77 |
1.75 |
0.91 |
2.10 |
|
| Inventory Turnover Ratio (X) |
8.77 |
0.82 |
0.63 |
0.75 |
0.73 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
106,921.55 |
91,268.07 |
0.00 |
0.00 |
0.00 |
|
| EV/Net Operating Revenue (X) |
11.26 |
9.85 |
0.00 |
0.00 |
0.00 |
|
| EV/EBITDA (X) |
34.99 |
35.21 |
0.00 |
0.00 |
0.00 |
|
| MarketCap/Net Operating Revenue (X) |
10.53 |
9.93 |
0.00 |
0.00 |
0.00 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
6.83 |
9.56 |
0.00 |
0.00 |
0.00 |
|
| Price/Net Operating Revenue |
10.53 |
9.93 |
0.00 |
0.00 |
0.00 |
|
| Earnings Yield |
0.02 |
0.02 |
0.00 |
0.00 |
0.00 |
|
Source : Dion Global Solutions Limited
